Last reviewed · How we verify
Antipsychotic Reduction
Antipsychotic Reduction is a Small molecule drug developed by University College, London. It is currently FDA-approved.
Researchers have studied various antipsychotic medications, including aripiprazole, olanzapine, and risperidone, in clinical trials for conditions such as psychotic disorders and schizophrenia. These trials have investigated the effects of these medications on symptoms and potential side effects, but no specific information is available on "Antipsychotic Reduction" as a distinct concept.
At a glance
| Generic name | Antipsychotic Reduction |
|---|---|
| Sponsor | University College, London |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Medication Adherence in Severe Mental Illness: a Promotion Program (NA)
- Predictive Validity of the Personal and Social Performance Scale for PANSS Outcomes in Schizophrenia (PHASE2)
- Caplyta in Borderline Personality Disorder (PHASE2)
- Effect of SC-ICBT for Adults With OCD：A Three-Arm Randomized Controlled Trial (NA)
- Effectiveness of a Pragmatic, Metabolic Care Clinic for Patients With Severe Mental Illness - The Meta Care Clinic (NA)
- Sequential Multiple Assignment Randomized Trial for Bipolar Depression (PHASE4)
- R33: Levetiracetam in Early Psychosis (PHASE2)
- Estimating and Reducing the Cardiovascular Risk of Patients With Schizophrenia Drugs From Lipid Measures and Ischemic Electrocardiographic Changes (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Antipsychotic Reduction CI brief — competitive landscape report
- Antipsychotic Reduction updates RSS · CI watch RSS
- University College, London portfolio CI
Frequently asked questions about Antipsychotic Reduction
What is Antipsychotic Reduction?
Who makes Antipsychotic Reduction?
What development phase is Antipsychotic Reduction in?
Related
- Manufacturer: University College, London — full pipeline
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing